S&P ASX All Technology

3,950.10

0.89%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TECH Bio Techne Corporation

75.38

0.51 (0.68%)

28 Nov 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Bio Techne (NASDAQ:TECH)
Historical Stock Chart
From Oct 2024 to Nov 2024

Bio Techne (NASDAQ:TECH)
Historical Stock Chart
From Nov 2023 to Nov 2024

Bio Techne Corporation News

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
Wednesday 27 November 2024 (19 hours ago) • PR Newswire (US)

Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne
Tuesday 26 November 2024 (3 days ago) • PR Newswire (US)

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
Wednesday 20 November 2024 (1 week ago) • PR Newswire (US)

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
Thursday 14 November 2024 (2 weeks ago) • PR Newswire (US)

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
Tuesday 12 November 2024 (2 weeks ago) • PR Newswire (US)

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
Monday 11 November 2024 (2 weeks ago) • PR Newswire (US)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 9 November 2024 (3 weeks ago) • Edgar (US Regulatory)

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
Friday 8 November 2024 (3 weeks ago) • PR Newswire (US)

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
Thursday 7 November 2024 (3 weeks ago) • PR Newswire (US)

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
Wednesday 6 November 2024 (3 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 November 2024 (3 weeks ago) • Edgar (US Regulatory)

More Bio Techne Corporation News Articles

GATE

CKBETH

Nervos Common Knowledge Base

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TECH Bio Techne Corporation

Bio Techne Corporation News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TECH Bio Techne Corporation

Bio Techne Corporation News

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%